A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948)
Elizabeth Smyth,Samuel Rowley,William Allum,Sally Stenning,Andrew Wotherspoon,C. Robb,Heike I. Grabsch,Derek Alderson,Tom Crosby,Robert M. Mason,S M Griffin,Was Mansoor,Suzanne Darby,Michel Seymour,Joyce Thompson,S. Sothi,Kate Sumpter,Jane Blazeby,Ruth E. Langley,David Cunningham
出处
期刊：Annals of Oncology [Elsevier BV] 日期：2016-10-01卷期号：27: vi562-vi562被引量：2
PDF的下载单位、IP信息已删除
(2025-6-4)
璐璐
v0id
嘻嘻哈哈
林狗
我能私信骂你吗
changping
渡人舟
科研狗
学术文献互助
谢雷XIELei
aaaa
CarryLJR
整齐的孤菱
maxiaole
aajhajkahna
xing_xing
invisight
极限001
pluto
牧青
皖公网安备34019202002308
